Humacyte, Inc. (HUMA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Humacyte, Inc. (HUMA).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $2.47

Daily Change: +$0.26 / 10.53%

Daily Range: $2.22 - $2.51

Market Cap: $383,143,968

Daily Volume: 4,617,972

Performance Metrics

1 Week: 2.92%

1 Month: -2.76%

3 Months: 102.5%

6 Months: -42.56%

1 Year: -68.61%

YTD: -51.09%

Company Details

Employees: 220

Sector: Health technology

Industry: Biotechnology

Country:

Details

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Selected stocks

TIAN RUIXIANG Holdings Ltd (TIRX)

Cycurion, Inc. (CYCU)

Heartbeam, Inc. (BEAT)